ARCHIVES

Rep. Wyden Questions NCI Motive For Choosing Not To Pursue RU 486

This article is from The Cancer Letter archive.

Vol. 18 No. 34 | September 4, 1992

Download PDF Visit The Full Archive

Related Articles

FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight

December 17, 2010

Arbuck Leaves NCI to Guide BMS Oncology Pipeline.

September 7, 2001

MRI Effective For Women With BRCA Gene Mutations

September 24, 2004

In Brief: Day, Foti Lead Coalition; Harkin Ends Campaigns; UT Southwestern Recieves $85 Mil. In Donations

March 13, 1992

Bennett Of NYU Heads NCI Director Search Committee

March 11, 1977

Trombold Tells How Scripps Raises Money for Cancer Center, Gets Independent From “Whiny Administrator”

April 5, 1985